The global regulatory information management system market size surpassed USD 2.10 billion in 2023 and is estimated to increase from USD 2.32 billion in 2024 to approximately USD 6.25 billion by 2034. It is projected to grow at a CAGR of 10.42% from 2024 to 2034.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Regulatory Information Management System Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Regulatory Information Management System Market, by Component, 2024-2034
8.1.1. Software
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Services
8.1.2.1. Market Revenue and Forecast (2021-2034)
9.1. Regulatory Information Management System Market, by Deployment, 2024-2034
9.1.1. On-premises
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Cloud-based
9.1.2.1. Market Revenue and Forecast (2021-2034)
10.1. Regulatory Information Management System Market, by Enterprise Size, 2024-2034
10.1.1. SMEs
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Large Enterprises
10.1.2.1. Market Revenue and Forecast (2021-2034)
11.1. Regulatory Information Management System Market, by End-use, 2024-2034
11.1.1. Pharmaceutical
11.1.1.1. Market Revenue and Forecast (2021-2034)
11.1.2. Biotechnology
11.1.2.1. Market Revenue and Forecast (2021-2034)
11.1.3. Clinical Research Organization
11.1.3.1. Market Revenue and Forecast (2021-2034)
12.1. North America
12.1.1. Market Revenue and Forecast, by Component (2021-2034)
12.1.2. Market Revenue and Forecast, by Deployment (2021-2034)
12.1.3. Market Revenue and Forecast, by Enterprise Size (2021-2034)
12.1.4. Market Revenue and Forecast, by End-use (2021-2034)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Component (2021-2034)
12.1.5.2. Market Revenue and Forecast, by Deployment (2021-2034)
12.1.5.3. Market Revenue and Forecast, by Enterprise Size (2021-2034)
12.1.5.4. Market Revenue and Forecast, by End-use (2021-2034)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Component (2021-2034)
12.1.6.2. Market Revenue and Forecast, by Deployment (2021-2034)
12.1.6.3. Market Revenue and Forecast, by Enterprise Size (2021-2034)
12.1.6.4. Market Revenue and Forecast, by End-use (2021-2034)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Component (2021-2034)
12.2.2. Market Revenue and Forecast, by Deployment (2021-2034)
12.2.3. Market Revenue and Forecast, by Enterprise Size (2021-2034)
12.2.4. Market Revenue and Forecast, by End-use (2021-2034)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Component (2021-2034)
12.2.5.2. Market Revenue and Forecast, by Deployment (2021-2034)
12.2.5.3. Market Revenue and Forecast, by Enterprise Size (2021-2034)
12.2.5.4. Market Revenue and Forecast, by End-use (2021-2034)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Component (2021-2034)
12.2.6.2. Market Revenue and Forecast, by Deployment (2021-2034)
12.2.6.3. Market Revenue and Forecast, by Enterprise Size (2021-2034)
12.2.6.4. Market Revenue and Forecast, by End-use (2021-2034)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Component (2021-2034)
12.2.7.2. Market Revenue and Forecast, by Deployment (2021-2034)
12.2.7.3. Market Revenue and Forecast, by Enterprise Size (2021-2034)
12.2.7.4. Market Revenue and Forecast, by End-use (2021-2034)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Component (2021-2034)
12.2.8.2. Market Revenue and Forecast, by Deployment (2021-2034)
12.2.8.3. Market Revenue and Forecast, by Enterprise Size (2021-2034)
12.2.8.4. Market Revenue and Forecast, by End-use (2021-2034)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Component (2021-2034)
12.3.2. Market Revenue and Forecast, by Deployment (2021-2034)
12.3.3. Market Revenue and Forecast, by Enterprise Size (2021-2034)
12.3.4. Market Revenue and Forecast, by End-use (2021-2034)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Component (2021-2034)
12.3.5.2. Market Revenue and Forecast, by Deployment (2021-2034)
12.3.5.3. Market Revenue and Forecast, by Enterprise Size (2021-2034)
12.3.5.4. Market Revenue and Forecast, by End-use (2021-2034)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Component (2021-2034)
12.3.6.2. Market Revenue and Forecast, by Deployment (2021-2034)
12.3.6.3. Market Revenue and Forecast, by Enterprise Size (2021-2034)
12.3.6.4. Market Revenue and Forecast, by End-use (2021-2034)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Component (2021-2034)
12.3.7.2. Market Revenue and Forecast, by Deployment (2021-2034)
12.3.7.3. Market Revenue and Forecast, by Enterprise Size (2021-2034)
12.3.7.4. Market Revenue and Forecast, by End-use (2021-2034)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Component (2021-2034)
12.3.8.2. Market Revenue and Forecast, by Deployment (2021-2034)
12.3.8.3. Market Revenue and Forecast, by Enterprise Size (2021-2034)
12.3.8.4. Market Revenue and Forecast, by End-use (2021-2034)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Component (2021-2034)
12.4.2. Market Revenue and Forecast, by Deployment (2021-2034)
12.4.3. Market Revenue and Forecast, by Enterprise Size (2021-2034)
12.4.4. Market Revenue and Forecast, by End-use (2021-2034)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Component (2021-2034)
12.4.5.2. Market Revenue and Forecast, by Deployment (2021-2034)
12.4.5.3. Market Revenue and Forecast, by Enterprise Size (2021-2034)
12.4.5.4. Market Revenue and Forecast, by End-use (2021-2034)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Component (2021-2034)
12.4.6.2. Market Revenue and Forecast, by Deployment (2021-2034)
12.4.6.3. Market Revenue and Forecast, by Enterprise Size (2021-2034)
12.4.6.4. Market Revenue and Forecast, by End-use (2021-2034)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Component (2021-2034)
12.4.7.2. Market Revenue and Forecast, by Deployment (2021-2034)
12.4.7.3. Market Revenue and Forecast, by Enterprise Size (2021-2034)
12.4.7.4. Market Revenue and Forecast, by End-use (2021-2034)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Component (2021-2034)
12.4.8.2. Market Revenue and Forecast, by Deployment (2021-2034)
12.4.8.3. Market Revenue and Forecast, by Enterprise Size (2021-2034)
12.4.8.4. Market Revenue and Forecast, by End-use (2021-2034)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Component (2021-2034)
12.5.2. Market Revenue and Forecast, by Deployment (2021-2034)
12.5.3. Market Revenue and Forecast, by Enterprise Size (2021-2034)
12.5.4. Market Revenue and Forecast, by End-use (2021-2034)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Component (2021-2034)
12.5.5.2. Market Revenue and Forecast, by Deployment (2021-2034)
12.5.5.3. Market Revenue and Forecast, by Enterprise Size (2021-2034)
12.5.5.4. Market Revenue and Forecast, by End-use (2021-2034)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Component (2021-2034)
12.5.6.2. Market Revenue and Forecast, by Deployment (2021-2034)
12.5.6.3. Market Revenue and Forecast, by Enterprise Size (2021-2034)
12.5.6.4. Market Revenue and Forecast, by End-use (2021-2034)
13.1. Veeva Systems
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Kalypso (Rockwell Automation)
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. DDi
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Körber AG
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. ArisGlobal
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. PhlexGlobal
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. MasterControl
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Rimsys
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Ithos Global Inc. (Cordance Group)
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. LORENZ Life Sciences Group
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample